Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/25/20244:05PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
06/25/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRAIMarpai Inc
06/25/20244:05PMBusiness WireGroupe Santé Devonian publie ses états financiers pour son troisième trimestre de 2024, une mise à jour de ses activités et l’engagement d’une firme de relation aux investisseursNASDAQ:GSDGlobal Systems Dynamics Inc
06/25/20244:05PMGlobeNewswire Inc.Tyson Foods Announces Third Quarter Earnings Conference Call and WebcastNYSE:TSNTyson Foods
06/25/20244:05PMGlobeNewswire Inc.Healthcare Realty Trust Announces Appointment of Thomas N. Bohjalian to Its Board of DirectorsNYSE:HRHealthcare Realty Trust Incorporated
06/25/20244:05PMBusiness WireAxos Financial, Inc. to Announce Fourth Quarter Fiscal 2024 Results on July 30, 2024NYSE:AXAxos Financial Inc
06/25/20244:05PMBusiness WireUSDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine InfluenzaNYSE:MRKMerck and Co Inc
06/25/20244:05PMPR Newswire (Canada)PROPEL REPORTS ON VOTING RESULTS FROM ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERSTSX:PRLPropel Holdings Inc
06/25/20244:05PMBusiness WireHelen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2025 ResultsNASDAQ:HELEHelen of Troy Ltd
06/25/20244:05PMGlobeNewswire Inc.LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockNASDAQ:LFMDLifeMD Inc
06/25/20244:05PMGlobeNewswire Inc.Methode Electronics Appoints Jon DeGaynor as President and CEONYSE:MEIMethode Electronics Inc
06/25/20244:05PMGlobeNewswire Inc.Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National ConferenceNASDAQ:QNRXQuoin Pharmaceuticals Ltd
06/25/20244:05PMGlobeNewswire Inc.Nasdaq to Hold Second Quarter 2024 Investor Conference CallNASDAQ:NDAQNasdaq Inc
06/25/20244:05PMBusiness WireAbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:ABCLAbCellera Biologics Inc
06/25/20244:05PMBusiness WireCitizens Financial Group Announces Second Quarter 2024 Earnings Conference Call DetailsNYSE:CFGCitizens Financial Group Inc
06/25/20244:05PMGlobeNewswire Inc.Tecnoglass Board of Directors Announces Review of Strategic AlternativesNYSE:TGLSTecnoglass Inc
06/25/20244:05PMGlobeNewswire Inc.LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockNASDAQ:LFMDPLifeMD Inc
06/25/20244:05PMGlobeNewswire Inc.Zihlschlacht Rehabilitation Clinic Appointed as the First DIH Center of Excellence in SwitzerlandNASDAQ:DHAIDIH Holdings US Inc
06/25/20244:05PMBusiness WireDomo Named to the 2024 ParityLIST, a Parity.Org Program Recognizing the Best Companies for Equal Advancement OpportunityNASDAQ:DOMODomo Inc
06/25/20244:04PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
06/25/20244:04PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
06/25/20244:04PMBusiness WireFedEx Reports Higher Full-Year Diluted EPS of $17.21 and Adjusted Diluted EPS of $17.80NYSE:FDXFedEx Corp
06/25/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SIVBPSVB Financial Group
06/25/20244:03PMPR Newswire (US)Sterne Kessler Earns "Top Workplaces" Recognition from The Washington Post for Eleventh Consecutive Year
06/25/20244:02PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
06/25/20244:02PMEdgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNASDAQ:OBNKOrigin Bancorp Inc
06/25/20244:02PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:RYBPFRoyal Bank (PK)
06/25/20244:02PMPR Newswire (Canada)Government of Canada supports local festivals in Sherbrooke
06/25/20244:02PMGlobeNewswire Inc.Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety ProfileNASDAQ:ALLKAllakos Inc
06/25/20244:02PMPR Newswire (Canada)Le gouvernement du Canada soutient des festivals locaux à Sherbrooke